Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Accéder directement au contenu
Article Dans Une Revue Oncotarget Année : 2015

Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis

Résumé

Activated in response to chemotherapy, senescence is a tumor suppressive mechanism that induces a permanent loss of proliferation. However, in response to treatment, it is not really known how cells can escape senescence and how irreversible or incomplete this pathway is. We have recently described that cells that escape senescence are more transformed than non-treated parental cells, they resist anoikis and rely on Mcl-1. In this study, we further characterize this emergence in response to irinotecan, a first line treatment used in colorectal cancer. Our results indicate that Akt was activated as a feedback pathway during the early step of senescence. The inhibition of the kinase prevented cell emergence and improved treatment efficacy, both in vitro and in vivo. This improvement was correlated with senescence inhibition, p21waf1 downregulation and a concomitant activation of apoptosis due to Noxa upregulation and Mcl-1 inactivation. The inactivation of Noxa prevented apoptosis and increased the number of emergent cells. Using either RNA interference or p21waf1-deficient cells, we further confirmed that an intact p53-p21-senescence pathway favored cell emergence and that its downregulation improved treatment efficacy through apoptosis induction. Therefore, although senescence is an efficient suppressive mechanism, it also generates more aggressive cells as a consequence of apoptosis inhibition. We therefore propose that senescence-inducing therapies should be used sequentially with drugs favoring cell death such as Akt inhibitors. This should reduce cell emergence and tumor relapse through a combined induction of senescence and apoptosis.

Domaines

Cancer
Fichier principal
Vignette du fichier
oncotarget-06-43342.pdf (11.04 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

inserm-01819855 , version 1 (21-06-2018)

Identifiants

Citer

Alexandra Vétillard, Barbara Jonchère, Marie Moreau, Bertrand Toutain, Cécile Henry, et al.. Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis. Oncotarget, 2015, 6 (41), pp.43342-62. ⟨10.18632/oncotarget.6126⟩. ⟨inserm-01819855⟩
228 Consultations
96 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More